3rd Circ. Won't Revive Cephalon Shareholder Case
A federal appeals court has refused to revive a Cephalon Inc. shareholder's suit accusing the company's board and CEO of failing to properly oversee sales and promotions practices for the drugs...To view the full article, register now.
Already a subscriber? Click here to view full article